AUB ScholarWorks

Ethical issues and risk-benefit assessment of iron chelation therapy: Advances with deferiprone-deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search AUB ScholarWorks


Browse

My Account